Strata Critical Medical (SRTA) Non-Current Assets (2019 - 2026)

Strata Critical Medical (SRTA) has 8 years of Non-Current Assets data on file, last reported at $203.5 million in Q1 2026.

• Quarterly Non-Current Assets rose 107.12% year-over-year to $203.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $716.8 million (up 77.96% YoY) and the FY2025 annual result came in at $199.3 million, up 107.73% from the prior year.
• Non-Current Assets rose to $203.5 million in Q1 2026 per SRTA's latest filing, from $199.3 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $212.6 million in Q3 2025 and bottomed at $41.4 million in Q1 2022.
• The 5-year median for Non-Current Assets is $101.4 million (2025), against an average of $113.3 million.
• Peak annual rise in Non-Current Assets reached 1243.92% in 2022, while the deepest fall reached 85.13% in 2022.
• Tracing SRTA's Non-Current Assets over 5 years: stood at $106.9 million in 2022, then fell by 17.05% to $88.7 million in 2023, then advanced by 8.18% to $95.9 million in 2024, then soared by 107.73% to $199.3 million in 2025, then grew by 2.1% to $203.5 million in 2026.
• Per Business Quant, the three latest SRTA Non-Current Assets figures stand at $203.5 million (Q1 2026), $199.3 million (Q4 2025), and $212.6 million (Q3 2025).

Peer Comparison